Article Text

other Versions

Circulating markers of prognosis and response to treatment in patients with midgut carcinoid tumours

Statistics from

This is a PDF-only article. The first page of the PDF of this article appears below.

PDF extract preview
  • Competing interests: GT had one year of salary paid by Novartis Pharmaceuticals while undertaking this research. There are no other conflicts of interest.

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Linked Articles

    • Digest
      Robin Spiller Alastair Watson